Flavanol plasma bioavailability is affected by metabolic syndrome in rats

Abstract

Flavanols, which exert several health benefits, are metabolized after ingestion. Factors such as the host physiological condition could affect the metabolism and bioavailability of flavanols, influencing their bioactivities. This study aimed to qualitatively evaluate whether a pathological state influenced flavanol plasma bioavailability. Standard and cafeteria (CAF) diet fed rats, a robust model of metabolic syndrome (MeS), were administered 1000mg/kg of flavanol enriched grape seed polyphenol extract (GSPE). Flavanols and their metabolites were quantified by HPLC-MS/MS in plasma before and at 2, 4, 7, 24, and 48h after GSPE ingestion. Results showed that in CAF administered rats the maximum time of plasma flavanol concentration was delayed and these animals presented higher levels of plasma phase-II metabolites as well as altered microbial metabolites. In conclusion, this study demonstrated that MeS pathological state modified flavanol bioavailability, supporting the hypothesis that flavanol metabolism, and therefore flavanol functionality, depend on the organism's state of health.

Keywords: (+)-Catechin (PubChem CID: 9064); (−)-Epicatechin (PubChem CID: 72276); 2-(3,4-Dihydroxyphenyl)acetic acid (PubChem CID: 547); 3-(4-Hydroxyphenyl)propionic acid (PubChem CID: 10394); 3-O-Methylgallic acid (CID: 19829); Benzoic acid (PubChem CID: 243); Bioactivity; Cafeteria diet; Gallic acid (PubChem CID: 370); Hippuric acid (PubChem CID: 464); Kinetic profile; Metabolism; Obesity; Polyphenols; Procyanidin B2 (PubChem CID: 122738); Vanillic acid (PubChem CID: 8468).